Evidence map›Paper›PMID 37262056›Full record

ArticlePloS one2023

Clinical characteristics and outcomes of hospitalized patients with COVID-19 in a city of South Brazil: Have they changed through the first year of the pandemic?

Henrique Demeneck, André Luiz Parmegiani de Oliveira, Julia do Carmo Machado Kneipp Lopes, Leonardo Ryoiti Matsunago, Luiza Cavalca Grupenmacher, Marcos Roberto Curcio Pereira, Rebecca Benício Stocco, Salma Ali El Chab Parolin, Marcia Olandoski, Cristina Pellegrino Baena

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Henrique DemeneckPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.ORCID 0000-0002-9509-9474
André Luiz Parmegiani de OliveiraPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Julia do Carmo Machado Kneipp LopesPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Leonardo Ryoiti MatsunagoPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Luiza Cavalca GrupenmacherPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Marcos Roberto Curcio PereiraPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Rebecca Benício StoccoPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Salma Ali El Chab ParolinPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Marcia OlandoskiPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
Cristina Pellegrino BaenaPostgraduate Program in Health Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.ORCID 0000-0002-5822-6622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic posed various challenges to the healthcare system and disease management. This study aimed to describe changes in the clinical characteristics and outcomes of hospitalized patients during the first year of the COVID-19 pandemic in a city in southern Brazil. This prospective study was carried out in two tertiary care private hospitals in Curitiba. A total of 1151 patients hospitalized between March 2020 and March 2021 were included. We identified three epidemiological critical periods of the pandemic and compared patients' characteristics and the frequencies of oral intubation, intensive care unit (ICU) admission and mortality. Continuous variables were analyzed by variance analysis model (ANOVA) or the Kruskal-Wallis nonparametric test and categorical variables by the chi-square or Fisher's exact test. Models for univariate and multivariate logistic regression analysis were adjusted to identify the factors associated with mortality. All p-values were two-tailed and p<0.05 was considered statistically significant. The average age of the patients was 58 years and 60.9% (n = 701) were males. The most prevalent comorbidities were systemic arterial hypertension, diabetes and obesity. There were no significant variations in the demographic characteristics and previous comorbidities of the patients for the different periods of analysis. Mortality was positively associated with the age ≥65 years and the presence of one or more cardiometabolic comorbidities (p<0.001). March 2021 was the most important critical period of the pandemic since there were higher frequencies of patients admitted later in the course of the disease, with desaturation and more symptoms at hospital admission (p<0.001). There was also an increase in the duration of hospital stay (p<0.001) and the frequencies of all critical outcomes for this period: oral intubation (p<0.001), ICU admission (p = 0.606) and mortality (p = 0.001). Our key findings revealed that, although there were no statistically significant differences between the subgroups of hospitalized patients over time in terms of demographic characteristics and comorbidities, the course of COVID-19 was significantly more severe for patients admitted to the hospital at the end of the first year of the pandemic in Brazil.

Indexed as

COVID-19AgedBrazilFemaleHumansIntensive Care UnitsMaleMiddle AgedPandemicsProspective StudiesRetrospective StudiesSARS-CoV-2

Identifiers

PMID37262056
PMCPMC10234546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.